Primary Record
prostaglandin A2
- In stock
- 8,142 g
- Purity
- 98.6 %
- CAS
- 13345-50-1
Compound Identifiers & Properties
- CAS
- 13345-50-1
- PubChem CID
- 5280880
- SMILES
- CCCCC[C@@H](/C=C/[C@H]1C=CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O
- Canonical SMILES
- CCCCC[C@H](O)/C=C/[C@H]1C=CC(=O)[C@@H]1C/C=C\CCCC(=O)O
Names & Synonyms
- prostaglandin A2
- Medullin
- PGA2
- (+)-Prostaglandin A2
- 5,6-cis-PGA2
- (15S)-Prostaglandin A2
- PGA2;Medullin
- prostaglandin-a-2
- 13345-50-1
- PGA(sup 2)
- K6VT5BDY9E
- (+)-Prostaglandin A(sup 2)
- Prostaglandin A(sup 2)
- (15S)-PGA2
- AC1NQXPP
- UNII-K6VT5BDY9E
- 5,6-cis-PGA(sup 2)
- 15(S)-Prostaglandin A2
- Pga2(prostaglandin a2)
- PGA2 (Prostaglandin A2)
- RefChem:176602
- Prostaglandin A2 solution
- 11-Deoxy-delta10PGE2
- CHEBI:27820
- D07LNY
- Dinoprostone EP Impurity D
- BSPBio_001460
- MLS000069589
- MYHXHCUNDDAEOZ-FOSBLDSVSA-N
- BML1-F02
- GTPL6279
- SCHEMBL2115595
- (155)-PGA2
- C20H30O4
- CHEMBL1084643
- NSC 165561
- BRN 2221844
- DTXSID20864388
- PROSTAGLANDIN A2 (PGA2)
- HMS1361I22
- HMS1791I22
- HMS1989I22
- HMS3402I22
- HMS3648I11
- NSC-165561
- ZINC4521813
- 1999AH
- BDBM50409489
- LMFA03010035
- MFCD00077859
- AKOS040755328
- MSK15542-100A
- C20-H30-O4
- CID5280880
- CID:5280880
- IDI1_033930
- 9-oxo-15S-hydroxy-5Z,10Z,13E-prostatrienoic acid
- Dinoprostone EP Impurity D (Free Base)
- NCGC00022061-03
- NCGC00022061-04
- NCGC00022061-05
- J15.713I
- SID:53788336
- SMR000058790
- HY-113041
- LS-125845
- CS-0059420
- DINOPROSTONE IMPURITY D [EP IMPURITY]
- FT-0630401
- (5Z,13E,15S)-15-hydroxy-9-oxoprosta-5,10,13-trien-1-oic acid
- C05953
- G91176
- 15(S)-Hydroxy-9-oxo-5-cis-10,13-trans-prostatrienoic acid
- (Z)-7-[(1R,2S)-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopent-3-en-1-yl]hept-5-enoic acid
- C100008
- Prosta-5,10,13-trien-1-oic acid, 15-hydroxy-9-oxo-, (5Z,13E,15S)-
- Prosta-5,10,13-trien-1-oicacid, 15-hydroxy-9-oxo-, (5Z,13E,15S)-
- SR-01000946222
- 15(S)-Hydroxy-9-oxo-5-cis-10,13-trans-prostenoic acid
- A1247043
- SR-01000946222-1
- (5Z,13E,15S)-15-hydroxy-9-oxoprosta-5, 10,13-triene-1-oic acid
- 15(S)-Hydroxy-9-oxo-5-cis-10,13-trans-prostenoate
- BRD-K34782918-001-02-5
- Prostaglandin A2 Solution in Acetonitrile, 100ug/mL
- Q27088462
- 15a-Hydroxy-9-oxo-cis-5,10,trans-13-prostatrienoate
- 5-Heptenoic acid, 7-(2-(3-hydroxy-1-octenyl)-5-oxo-3-cyclopenten-1-yl)-
- (Z)-7-((1R,2S)-2-((E)-(3S)-3-hydroxyoct-1-enyl)-5-oxocyclopent-3-enyl)hept-5-enoic acid
- 15(S)-Hydroxy-9-oxo-5-cis-10,13-trans-prostatrienoate
- 15a-Hydroxy-9-oxo-cis-5,10,trans-13-prostatrienoic acid
- 15a-Hydroxy-9-oxo-cis-5,10,trans-13-prostatrienecarboxylate
- 362927F3-3A3E-47BC-84C3-C32A293AA956
- Prosta-5,10-13-trien-1-oic acid, 15-hydroxy-9-oxo-, (5Z,13E,15S)-
- (5Z,13E,15S)-15-Hydroxy-9-oxo-5,10,13-prostatrien-1-oic acid
- (5Z,13E,15S)-15-hydroxy-9-oxoprosta-5,10,13-trien-1-oate
- 15.alpha.-Hydroxy-9-oxo-cis-5,10,trans-13-prostatrienoic acid
- 15a-Hydroxy-9-oxo-cis-5,10,trans-13-prostatrienecarboxylic acid
- 5-Heptenoic acid, 7-(2-(3-hydroxy-1-octenyl)-5-oxo-3-cyclopenten-1-yl)- (VAN)
- (5Z,12S,13E,15S)-15-Hydroxy-9-oxoprosta-5,10,13-triene-1-oic acid
- (Z)-7-((1R,2S)-2-((S,E)-3-Hydroxyoct-1-en-1-yl)-5-oxocyclopent-3-en-1-yl)hept-5-enoic acid
- (Z)-7-[(1R,2S)-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxo-cyclopent-3-en-1-yl]hept-5-enoic acid
- 15.alpha.-Hydroxy-9-oxo-cis-5,10,trans-13-prostatrienecarboxylic acid
- (Z)-7-((1R,2S)-2-((E)-3-hydroxyoct-1-enyl)-5-oxocyclopent-3-en-1-yl)hept-5-enoic acid
- (~{Z})-7-[(1~{R},5~{S})-2-oxidanylidene-5-[(~{E},3~{S})-3-oxidanyloct-1-enyl]cyclopent-3-en-1-yl]hept-5-enoic acid
- (5Z)-7-[(1R,2S)-2-[(1E,3S)-3-Hydroxy-1-octenyl]-5-oxo-3-cyclopenten-1-yl]-5-heptenoic acid
- (5Z)-7-[(1R,2S)-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopent-3-en-1-yl]hept-5-enoic acid
- (5Z,13E,15S)-15-Hydroxy-9-oxoprosta-5,10,13-trien-1-oic Acid; 7-[2-(3-Hydroxy-1-octenyl)-5-oxo-3-cyclopenten-1-yl]-5-heptenoic Acid; (+)-Prostaglandin A2; (15S)-PGA2; 15(S)-Hydroxy-9-oxo-5-cis-
- (Z)-7-((1R,2S)-2-((E,3S)-3-hydroxyoct-1-enyl)-5-oxo-1-cyclopent-3-enyl)hept-5-enoic acid
- (Z)-7-((1R,2S)-2-((E,3S)-3-hydroxyoct-1-enyl)-5-oxocyclopent-3-en-1-yl)hept-5-enoic acid
- (Z)-7-[(1R,2S)-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxo-1-cyclopent-3-enyl]hept-5-enoic acid
- 10,13-trans-prostatrienoic Acid; 15(S)-Hydroxy-9-oxo-5-cis-10,13-trans-prostenoic Acid; 15(S)-Prostaglandin A2; 15a-Hydroxy-9-oxo-cis-5,10,trans-
- 13-prostatrienecarboxylic Acid; 15a-Hydroxy-9-oxo-cis-5,10,trans-13-prostatrienoic Acid; 5,6-cis-PGA2; Medullin; NSC 165561; PGA2;
- DINOPROSTONE IMPURITY, (5Z,13E,15S)-15-HYDROXY-9-OXOPROSTA-5, 10,13-TRIENE-1-OIC ACID- [USP IMPURITY]